Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

53
A 3.8% Dividend Yield? It's Still Not Hanmi Time

2018-08-13 seekingalpha
HAFC is a $5.4 billion-asset bank serving “multi-ethnic communities” through 40 full-service branches and 9 loan production offices in California, Texas, Illinois, Virginia, New Jersey, New York, Colorado, Washington and Georgia.
WFC BAC HAFC CATY HOPE JPM EWBC CATYW

92
BBCN / BBCN Bancorp Inc. - Stock Institutional Ownership and Shareholders - Fintel.io

2018-08-08 fintel.io
BBCN Bancorp Inc. (NASDAQ:BBCN) has 203 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 125,393,593 shares. Largest shareholders include BlackRock Inc., Vanguard Group Inc, BlackRock Fund Advisors, Dimensional Fund Advisors Lp, Fuller & Thaler Asset Management, Inc., Price T Rowe Associates Inc /md/, State Street Corp, Lsv Asset Management, BlackRock Institutional Trust Company, N.
STT HOPE NTRSP BBCN CGC TWMJF BLK NTRS WEED

0
HOPE / Hope Bancorp, Inc. 10-Q (Quarterly Report)

2018-08-06 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
HOPE

0
Hope Bancorp, Inc. 2018 Q2 - Results - Earnings Call Slides

2018-07-19 seekingalpha
The following slide deck was published by Hope Bancorp, Inc. in conjunction with their 2018 Q2 earnings call.
HOPE

0
Hope Bancorp, Inc. (HOPE) CEO Kevin Kim on Q2 2018 Results - Earnings Call Transcript

2018-07-18 seekingalpha
Good day and welcome to the Hope Bancorp Second Quarter 2018 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.
HOPE

0
Hope Bancorp Reports 2018 Second Quarter Financial Results

2018-07-17 globenewswire
LOS ANGELES, July 17, 2018 (GLOBE NEWSWIRE) -- Hope Bancorp, Inc. (the “Company”) (NASDAQ:HOPE), the holding company of Bank of Hope (the “Bank”), today reported unaudited financial results for the three and six months ended June 30, 2018. Net income for the 2018 second quarter totaled $47.5 million, or $0.36 per diluted common share, based on 133,352,841 weighted averaged diluted common shares outstanding.
HOPE

0
Hope Bancorp Increases Quarterly Cash Dividend to $0.14 per Share

2018-07-17 globenewswire
LOS ANGELES, July 17, 2018 (GLOBE NEWSWIRE) -- Hope Bancorp, Inc. (NASDAQ:HOPE) today announced that its Board of Directors approved an increase in the quarterly cash dividend to $0.14 per common share from $0.13 per common share. The dividend is payable on or about August 10, 2018 to all stockholders of record as of the close of business on July 27, 2018.
HOPE

285
Stocks To Watch: Prime Time In Retail

2018-07-14 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
ECOR PLNT PKG AEP NINE ADT GE COF-P GILD TMUS PDYPF SYF XERS JNJ VZ MSFT ADS KZR NNN EIDX FB AVRO HOPE NFLX AXP EHC BAC COF-D SEAS COF-C COF-F KR KS IIIV PNFP AAPL DDOC SJM INPAP SIX JPM GNE WRK LGEJY KMRFZ DE 39IB KMX RF UAL WMT CFIN LGEAF IP AMZN MGTA NTRS HON KMI CIWV HCSG KMR CVB VLKAY LGEIY EBAY EPRT STT SLB BAC DFS LGEPF STM BBY BX BK STM LTXB LGLD SLB FOXA CLW PM NTRSP AUTL DLPH SWKS GS SWK TRTX GM PII DIS NEE IBM MOR F GEC C CMCSA COF FUN FUL CFG HBAN XEL TGT BLK S PPG T SNE DPZ

3
Hope Bancorp to Announce 2018 Second Quarter Financial Results on Tuesday, July 17, 2018

2018-06-28 globenewswire
LOS ANGELES, June 28, 2018 (GLOBE NEWSWIRE) -- Hope Bancorp, Inc. (NASDAQ:HOPE) today announced that the company will announce financial results for its 2018 second quarter after the markets close on Tuesday, July 17, 2018.
HOPE

50
United Community Banks downgraded to hold vs. buy at SunTrust Robinson Humphrey

2018-06-26 marketwatch
KS Bancorp: Shareholders Should Reject The Proposal Of Conversion To Delaware Corporation And Pressure The Management For A Sale
SBNY SBNYW HOPE GPRE IEX UE.WI RHP ETH UBSH NFX UE HCKT DST IPGP UCBI REXR UNB RPM AKAM GHDX ECPG

3
Hope Bancorp, Inc. Announces Closing of Sale of Additional $17.5 Million Convertible Senior Notes

2018-06-08 globenewswire
LOS ANGELES, June 08, 2018 (GLOBE NEWSWIRE) -- Hope Bancorp, Inc. (NASDAQ:HOPE) (the “Company”) today announced that, in connection with its previously announced offering of $200.0 million aggregate principal amount of 2.00% Convertible Senior Notes due 2038 (the “Original Notes”), the initial purchaser has exercised in part its previously announced over-allotment option to purchase an additional $17.
HOPE

3
Hope Bancorp to Participate in KBW US Regional Leaders Bank Conference in London

2018-05-30 globenewswire
LOS ANGELES, May 30, 2018 (GLOBE NEWSWIRE) -- Hope Bancorp, Inc. (NASDAQ:HOPE) today announced that Chief Executive Officer Kevin S. Kim and Chief Financial Officer Alex Ko will be meeting with institutional investors at the KBW US Regional Bank Leaders Conference on Monday, June 4, 2018 in London.
HOPE

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

CUSIP: 073295107